General Information of Drug (ID:
DR2932) |
Drug Name |
MDL 101,731
|
Synonyms |
Tezacitabine; Fmdc cpd; 130306-02-4; Mdl 101,731; UNII-7607Y95N9S; Mdl 101731; (E)-2'-Deoxy-2'-(fluoromethylene) cytidine; MDL-101731; 2'-Deoxy-2'-(fluoromethylene)cytidine; 7607Y95N9S; Cytidine, 2'-deoxy-2'-(fluoromethylene)-, (2E)-; (E)-2'-Deoxy-2'-(fluoromethylene)cytidine; Tezacitabine [INN]; tezaciabine; Tezacitabine, anhydrous; AC1O5KIG; SCHEMBL18724; SCHEMBL18725; Tezacitabine, anhydrous [INN]; CHEMBL2105467; C10H12FN3O4; DTXSID10156446; GFFXZLZWLOBBLO-ASKVSEFXSA-N; ZINC3777826; KW-2331
|
Indication |
Stomach cancer
[ICD11: 2B72]
|
Discontinued in Phase 2
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
257.22 |
Topological Polar Surface Area |
108 |
Heavy Atom Count |
18 |
Rotatable Bond Count |
2 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 6435808
- CAS Number
-
- TTD Drug ID
- D05HZI
- Formula
- C10H12FN3O4
- Canonical SMILES
- C1=CN(C(=O)N=C1N)[C@H]2/C(=C/F)/[C@@H]([C@H](O2)CO)O
- InChI
- InChI=1S/C10H12FN3O4/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17/h1-3,6,8-9,15-16H,4H2,(H2,12,13,17)/b5-3+/t6-,8+,9-/m1/s1
- InChIKey
- GFFXZLZWLOBBLO-ASKVSEFXSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.